Does the time to start first-line treatment influence survival of patients with low risk kidney cancer?
Many patients with low-risk or favourable-risk kidney cancer may have [...]
Many patients with low-risk or favourable-risk kidney cancer may have [...]
A study published in the Journal of Hematology Oncology Pharmacy [...]
In a recent phase 3 clinical trial the combination of [...]
Small renal masses are areas of abnormal tissue growth in [...]
Adjuvant therapy is medication that is given after surgery to [...]
NHS England started a large-scale trial of a new blood [...]
Maintaining good health-related quality of life is important for all [...]
This study looked at real world data from people with [...]
A recent survey from the Association of the British Pharmaceutical [...]
Preliminary results from the COSMIC-313 clinical trial have ben released. [...]